Kappa Opioid Receptor Imaging in Depression (KOR Depression)
Phase of Trial: Phase IV
Latest Information Update: 19 Aug 2016
At a glance
- Drugs LY 2795050 (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
- Acronyms KOR Depression
- 29 Apr 2016 Status changed from completed to discontinued.
- 02 Mar 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 26 Jun 2015 Planned End Date changed from 1 Jul 2019 to 1 Dec 2015 as reported by ClinicalTrials.gov record.